Rotow, J: search on Z-Library

The world's largest scientific articles store. 70,000,000+ articles for free.

Don't use scam websites

1

Understanding and targeting resistance mechanisms in NSCLC

Rotow, Julia, Bivona, Trever G.

Journal:

Nature Reviews Cancer

Year:

2017

Language:

english

File:

PDF, 855 KB

english, 2017

2

Therapy-Induced Evolution of Human Lung Cancer Revealed by Single-Cell RNA Sequencing

Maynard, Ashley, McCoach, Caroline E., Rotow, Julia K., Harris, Lincoln, Haderk, Franziska, Kerr, D. Lucas, Yu, Elizabeth A., Schenk, Erin L., Tan, Weilun, Zee, Alexander, Tan, Michelle, Gui, Philippe

Journal:

Year:

2020

File:

PDF, 16.43 MB

2020

3

Pharmacokinetics, Clinical Indications, and Resistance Mechanisms in Molecular Targeted Therapies in Cancer

Izar, B., Rotow, J., Gainor, J., Clark, J., Chabner, B.

Journal:

Pharmacological Reviews

Year:

2013

Language:

english

File:

PDF, 1.43 MB

english, 2013

4

Image Orthicons for Color Cameras

Neuhauser, R.G., Rotow, A.A., Veith, F.S.

Journal:

Proceedings of the IRE

Year:

1954

Language:

english

File:

PDF, 1.12 MB

english, 1954

5

Vaccines as Monotherapy and in Combination Therapy for Prostate Cancer

Julia Rotow, Sofia R. Gameiro, Ravi A. Madan, James L. Gulley, Jeffrey Schlom, James W. Hodge

Journal:

Clinical and Translational Science

Year:

2010

Language:

english

File:

PDF, 15.12 MB

english, 2010

6

RBM5/H37 tumor suppressor, located at the lung cancer hot spot 3p21.3, alters expression of genes involved in metastasis

Oh, Juliana J., Taschereau, Eileen O., Koegel, Ashley K., Ginther, Charles L., Rotow, Julia K., Isfahani, Khadijeh Z., Slamon, Dennis J.

Journal:

Year:

2010

Language:

english

File:

PDF, 922 KB

english, 2010

7

Evolution and clinical impact of co-occurring genetic alterations in advanced-stage EGFR-mutant lung cancers

Blakely, Collin M, Watkins, Thomas B K, Wu, Wei, Gini, Beatrice, Chabon, Jacob J, McCoach, Caroline E, McGranahan, Nicholas, Wilson, Gareth A, Birkbak, Nicolai J, Olivas, Victor R, Rotow, Julia, Mayna

Journal:

Nature Genetics

Year:

2017

Language:

english

File:

PDF, 4.46 MB

english, 2017

8

Aurora kinase A drives the evolution of resistance to third-generation EGFR inhibitors in lung cancer

Shah, Khyati N., Bhatt, Roma, Rotow, Julia, Rohrberg, Julia, Olivas, Victor, Wang, Victoria E., Hemmati, Golzar, Martins, Maria M., Maynard, Ashley, Kuhn, Jonathan, Galeas, Jacqueline, Donnella, Hayle

Journal:

Nature Medicine

Year:

2018

Language:

english

File:

PDF, 1.94 MB

english, 2018

9

Differential subcellular localization regulates oncogenic signaling by ROS1 kinase fusion proteins

Neel, Dana S., Allegakoen, David V, Olivas, Victor, Mayekar, Manasi K, Hemmati, Golzar, Chatterjee, Nilanjana, Blakely, Collin M., McCoach, Caroline E, Rotow, Julia K, Le, Anh, Karachaliou, Niki, Rose

Journal:

Cancer Research

Year:

2018

Language:

english

File:

PDF, 5.78 MB

english, 2018

10

Pathologic Complete Response to Neoadjuvant Crizotinib in a Lung Adenocarcinoma Patient With a MET Exon 14 Skipping Mutation

Rotow, Julia K., Woodard, Gavitt A., Urisman, Anatoly, McCoach, Caroline E., Bivona, Trever G., Elicker, Brett M., Jablons, David M., Blakely, Collin M.

Journal:

Clinical Lung Cancer

Year:

2018

Language:

english

File:

PDF, 1.28 MB

english, 2018

11

A dual pathway inhibition strategy using BKM120 combined with vemurafenib is poorly tolerated in BRAF V600 E/K mutant advanced melanoma

Algazi, Alain Patrick, Rotow, Julia, Posch, Christian, Ortiz-Urda, Susana, Pelayo, Alyson, Munster, Pamela N., Daud, Adil

Journal:

Pigment Cell & Melanoma Research

Year:

2019

File:

PDF, 626 KB

2019

12

A dual pathway inhibition strategy using BKM120 combined with vemurafenib is poorly tolerated in BRAF V600 E/K mutant advanced melanoma

Algazi, Alain Patrick, Rotow, Julia, Posch, Christian, Ortiz-Urda, Susana, Pelayo, Alyson, Munster, Pamela N., Daud, Adil

Journal:

Pigment Cell & Melanoma Research

Year:

2019

Language:

english

File:

PDF, 626 KB

english, 2019

13

MA11.09 Single-Cell Characterization of the Immunologic Microenvironment in Advanced-Stage, Oncogene-Driven NSCLC

Rotow, J., Mccoach, C., Maynard, A., Naeger, D., Gesthalter, Y., Kolli, K.P., Darmanis, S., Bivona, T., Blakely, C., Weissman, J.

Journal:

Journal of Thoracic Oncology

Year:

2018

File:

PDF, 134 KB

2018

14

Co-occurring alterations in the RAS-MAPK pathway limit response to MET inhibitor treatment in MET exon 14 skipping mutation-positive lung cancer

Rotow, Julia K, Gui, Philippe, Wu, Wei, Raymond, Victoria M, Lanman, Richard B., Kaye, Frederic J, Peled, Nir, Fece de la Cruz, Ferran, Nadres, Brandon, Corcoran, Ryan B., Yeh, Iwei, Bastian, Boris C.

Journal:

Clinical Cancer Research

Year:

2019

Language:

english

File:

PDF, 3.54 MB

english, 2019

15

P1.14-58 A Phase II Study to Evaluate Neoadjuvant Osimertinib for Surgically Resectable, EGFR-Mutant Non-Small Cell Lung Cancer

Rotow, J., Urisman, A., Mccoach, C., Jahan, T., Bivona, T., Jones, K., Gupta, A., Do, H., Riess, J., Aisner, D., Doebele, R., Jablons, D., Kratz, J., Blakely, C.

Journal:

Journal of Thoracic Oncology

Year:

2019

Language:

english

File:

PDF, 117 KB

english, 2019

16

MA06.09 Timing of Driver Mutation Development and the Genetic Evolution of Semi-Solid Lung Nodules into Early NSCLC

Woodard, G., Ding, V., Kim, I., Jones, K., Chavez, G., Haro, G., Kratz, J., Mann, M., Rotow, J., Blakely, C., Jablons, D.

Journal:

Journal of Thoracic Oncology

Year:

2019

Language:

english

File:

PDF, 214 KB

english, 2019

17

Turnaround Time of Plasma Next-Generation Sequencing in Thoracic Oncology Patients: A Quality Improvement Analysis

Lee, Yi, Clark, Evan W., Milan, Marina S.D., Champagne, Christine, Michael, Kesi S., Awad, Mark M., Barbie, David A., Cheng, Michael L., Kehl, Kenneth L., Marcoux, J. Paul, Rabin, Michael S., Rotow, J

Journal:

JCO Precision Oncology

Year:

2020

File:

PDF, 1.19 MB

2020